Global Cell and Gene Therapy Manufacturing QC Market Research Report 2022

Global Cell and Gene Therapy Manufacturing QC Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing QC Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Manufacturing QC Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing QC Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2021
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Detail
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Detail
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Detail
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Detail
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Detail
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Detail
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Detail
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Detail
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Detail
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Detail
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Detail
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Detail
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Detail
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
11.15.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2017-2022)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2023-2028)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2017-2022)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2021)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
Table 24. Date of Enter into Cell and Gene Therapy Manufacturing QC Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2017-2022)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2023-2028)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2017-2022)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2023-2028)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2023-2028) & (US$ Million)
Table 44. Bio-Techne Corporation Company Detail
Table 45. Bio-Techne Corporation Business Overview
Table 46. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 47. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 48. Bio-Techne Corporation Recent Development
Table 49. BioMerieux SA Company Detail
Table 50. BioMerieux SA Business Overview
Table 51. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 52. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 53. BioMerieux SA Recent Development
Table 54. Catalent, Inc. Company Detail
Table 55. Catalent, Inc. Business Overview
Table 56. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 57. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 58. Catalent, Inc. Recent Development
Table 59. Charles River Laboratories International Inc. Company Detail
Table 60. Charles River Laboratories International Inc. Business Overview
Table 61. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 62. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 63. Charles River Laboratories International Inc. Recent Development
Table 64. Eurofins Scientific SE Company Detail
Table 65. Eurofins Scientific SE Business Overview
Table 66. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 67. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 68. Eurofins Scientific SE Recent Development
Table 69. F. Hoffmann-La Roche Ltd Company Detail
Table 70. F. Hoffmann-La Roche Ltd Business Overview
Table 71. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 72. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 73. F. Hoffmann-La Roche Ltd Recent Development
Table 74. Intertek Group plc Company Detail
Table 75. Intertek Group plc Business Overview
Table 76. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 77. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 78. Intertek Group plc Recent Development
Table 79. Lonza Group AG Company Detail
Table 80. Lonza Group AG Business Overview
Table 81. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product
Table 82. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 83. Lonza Group AG Recent Development
Table 84. Merck KGaA Company Detail
Table 85. Merck KGaA Business Overview
Table 86. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 87. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 88. Merck KGaA Recent Development
Table 89. Sartorius AG Company Detail
Table 90. Sartorius AG Business Overview
Table 91. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 92. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 93. Sartorius AG Recent Development
Table 94. SGS S.A. Company Detail
Table 95. SGS S.A. Business Overview
Table 96. SGS S.A. Cell and Gene Therapy Manufacturing QCProduct
Table 97. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 98. SGS S.A. Recent Development
Table 99. Sistemic Scotland Limited Company Detail
Table 100. Sistemic Scotland Limited Business Overview
Table 101. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QCProduct
Table 102. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 103. Sistemic Scotland Limited Recent Development
Table 104. Thermo Fisher Scientific Inc. Company Detail
Table 105. Thermo Fisher Scientific Inc. Business Overview
Table 106. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QCProduct
Table 107. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 108. Thermo Fisher Scientific Inc. Recent Development
Table 109. Vigene Biosciences, Inc. Company Detail
Table 110. Vigene Biosciences, Inc. Business Overview
Table 111. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QCProduct
Table 112. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 113. Vigene Biosciences, Inc. Recent Development
Table 114. WuXi AppTec Company Detail
Table 115. WuXi AppTec Business Overview
Table 116. WuXi AppTec Cell and Gene Therapy Manufacturing QCProduct
Table 117. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2017-2022) & (US$ Million)
Table 118. WuXi AppTec Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2021 VS 2028
Figure 2. Safety Testing Features
Figure 3. Purity Testing Features
Figure 4. Potency Testing Features
Figure 5. Identity Testing Features
Figure 6. Stability Testing Features
Figure 7. Global Cell and Gene Therapy Manufacturing QC Market Share by Application in 2021 & 2028
Figure 8. Precision Therapy Case Studies
Figure 9. Biological Research Case Studies
Figure 10. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 11. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell and Gene Therapy Manufacturing QC Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Share by Region: 2021 VS 2028
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2021
Figure 15. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2021
Figure 17. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2017-2028)
Figure 19. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2017-2028)
Figure 23. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2017-2028)
Figure 31. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Country (2017-2028)
Figure 39. Mexico Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Country (2017-2028)
Figure 43. Turkey Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 46. BioMerieux SA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 47. Catalent, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 48. Charles River Laboratories International Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 49. Eurofins Scientific SE Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 51. Intertek Group plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 52. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 53. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 54. Sartorius AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 55. SGS S.A. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 56. Sistemic Scotland Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 57. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 58. Vigene Biosciences, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 59. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs